Terms: = Head and neck cancer AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716
61 results:
1. [High LINC00626 expression promotes esophagogastric junction adenocarcinoma metastasis: the mediating role of the jak1/STAT3/KHSRP axis].
Zhang F; Fan L; Kang X; Wei H; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):541-552. PubMed ID: 38597446
[TBL] [Abstract] [Full Text] [Related]
2. Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission.
Guo YW; Zhu L; Duan YT; Hu YQ; Li LB; Fan WJ; Song FH; Cai YF; Liu YY; Zheng GW; Ge MH
Cell Death Dis; 2024 Feb; 15(2):125. PubMed ID: 38336839
[TBL] [Abstract] [Full Text] [Related]
3. Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation.
Lee M; Morris LG
Oncotarget; 2024 Jan; 15():36-48. PubMed ID: 38275291
[TBL] [Abstract] [Full Text] [Related]
4. WNT7A promotes tumorigenesis of head and neck squamous cell carcinoma via activating FZD7/jak1/STAT3 signaling.
Huang Q; Xiao Y; Lan T; Lu Y; Huang L; Zheng D
Int J Oral Sci; 2024 Jan; 16(1):7. PubMed ID: 38246919
[TBL] [Abstract] [Full Text] [Related]
5. RARγ promotes the invasion and metastasis of thyroid carcinoma by activating the jak1-STAT3-CD24/MMPs axis.
Zhang FX; Xu P; Zhang LJ; Fan R; Zhang HX; Liu DH; Liu K; Shen DY
Int Immunopharmacol; 2023 Dec; 125(Pt A):111129. PubMed ID: 37897947
[TBL] [Abstract] [Full Text] [Related]
6. cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/jak1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer.
Han N; Zhou D; Ruan M; Yan M; Zhang C
Oral Oncol; 2023 Oct; 145():106524. PubMed ID: 37482043
[TBL] [Abstract] [Full Text] [Related]
7. DACH1 regulates macrophage activation and tumour progression in hypopharyngeal squamous cell carcinoma.
Li W; Xu L; Cao J; Ge J; Liu X; Liu P; Teng Y; Wang S; Sun Y; Liu M; Tian L
Immunology; 2023 Oct; 170(2):253-269. PubMed ID: 37243970
[TBL] [Abstract] [Full Text] [Related]
8. DUSP4 promotes esophageal squamous cell carcinoma progression by dephosphorylating HSP90β.
Zhou L; Yao N; Yang L; Liu K; Qiao Y; Huang C; Du R; Yeung YT; Liu W; Cheng D; Dong Z; Li X
Cell Rep; 2023 May; 42(5):112445. PubMed ID: 37141098
[TBL] [Abstract] [Full Text] [Related]
9. FOXK1 regulates epithelial-mesenchymal transition and radiation sensitivity in nasopharyngeal carcinoma via the JAK/STAT3 signaling pathway.
Duan L; Huang J; Zhang Y; Pi G; Ying X; Zeng F; Hu D; Ma J
Genes Genomics; 2023 Jun; 45(6):749-761. PubMed ID: 37043129
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of ALK-Signaling Overcomes STRN-ALK-Induced Downregulation of the Sodium Iodine Symporter and Restores Radioiodine Uptake in Thyroid Cells.
Nikitski AV; Condello V; Divakaran SS; Nikiforov YE
Thyroid; 2023 Apr; 33(4):464-473. PubMed ID: 36585857
[No Abstract] [Full Text] [Related]
11. lncRNA MSC-AS1/miRNA-429 Axis Mediates Growth and Metastasis of Nasopharyngeal Carcinoma via jak1/STAT3 Signaling Pathway.
Luo N
Comput Math Methods Med; 2022; 2022():1447207. PubMed ID: 36213586
[TBL] [Abstract] [Full Text] [Related]
12. STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in head and neck cancer.
Qureshy Z; Li H; Zeng Y; Rivera J; Cheng N; Peterson CN; Kim MO; Ryan WR; Ha PK; Bauman JE; Wang SJ; Long SR; Johnson DE; Grandis JR
Clin Cancer Res; 2022 Nov; 28(21):4737-4746. PubMed ID: 35929989
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of ribophorin II is required for viability of nasopharyngeal cancer cells by regulating jak1/STAT3 activation.
Wang B; Liu W; Jiang X; Li J; Hu X; Li L; Gu Q
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):471-477. PubMed ID: 34184962
[TBL] [Abstract] [Full Text] [Related]
14. Feed-forward activation of STAT3 signaling limits the efficacy of c-Met inhibitors in esophageal squamous cell carcinoma (ESCC) treatment.
Zhao D; Chen J; Wang Y; Zhang L; Zhang J; Zhang W; Fan J; Li J; Zhan Q
Mol Carcinog; 2021 Jul; 60(7):481-496. PubMed ID: 34018249
[TBL] [Abstract] [Full Text] [Related]
15. Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer.
Cui Y; Guo W; Li Y; Shi J; Ma S; Guan F
Esophagus; 2021 Apr; 18(2):326-338. PubMed ID: 33175267
[TBL] [Abstract] [Full Text] [Related]
16. Circular RNA DOCK1 downregulates microRNA-124 to induce the growth of human thyroid cancer cell lines.
Cui W; Xue J
Biofactors; 2020 Jul; 46(4):591-599. PubMed ID: 32584497
[TBL] [Abstract] [Full Text] [Related]
17. Added value of metastatic cervical lymph node group V in nodal staging of nasopharyngeal cancer.
Setakornnukul J; Thephamongkhol K; Chaysiri P
Head Neck; 2020 Oct; 42(10):2801-2810. PubMed ID: 32542997
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of esophageal-carcinoma cell proliferation by genistein via suppression of jak1/2-STAT3 and AKT/MDM2/p53 signaling pathways.
Gao J; Xia R; Chen J; Gao J; Luo X; Ke C; Ren C; Li J; Mi Y
Aging (Albany NY); 2020 Apr; 12(7):6240-6259. PubMed ID: 32276266
[TBL] [Abstract] [Full Text] [Related]
19. MiR-769-5p inhibits cancer progression in oral squamous cell carcinoma by directly targeting jak1/STAT3 pathway.
Zhou Y; Xu XM; Feng Y
Neoplasma; 2020 May; 67(3):528-536. PubMed ID: 32064884
[TBL] [Abstract] [Full Text] [Related]
20. Anticancer effects of NSC‑631570 (Ukrain) in head and neck cancer cells: In vitro analysis of growth, invasion, angiogenesis and gene expression.
Herrmann R; Skaf J; Roller J; Polednik C; Holzgrabe U; Schmidt M
Oncol Rep; 2020 Jan; 43(1):282-295. PubMed ID: 31789425
[TBL] [Abstract] [Full Text] [Related]
[Next]
